Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunction

Catheterization and Cardiovascular Interventions

Volumn 80, Issue 7, 2012, Pages 1201-1209

  Martinez, Claudia A ^a   Singh, Vikas ^a   Londoño, Juan C ^a,b   Cohen, Mauricio G ^a   Alfonso, Carlos E ^a   O'Neill, William W ^a   Heldman, Alan W ^a  

^a UNIVERSITY OF MIAMI HOSPITAL   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

aortic balloon valvuloplasty; aortic stenosis; Impella 2.5; left ventricular assist device; percutaneous coronary intervention

Indexed keywords

ADRENALIN; DOBUTAMINE; NORADRENALIN; PHENYLEPHRINE;

AGED; AORTA PRESSURE; AORTA VALVE STENOSIS; AORTIC VALVE REPAIR; ARTICLE; BALLOON AORTIC VALVULOPLASTY; BLOOD TRANSFUSION; CARDIOGENIC SHOCK; CLINICAL ARTICLE; COMPLETE HEART BLOCK; FEMALE; HEART ARREST; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HEMATOMA; HIGH RISK PATIENT; HUMAN; HYPOTENSION; LEFT VENTRICULAR ASSIST DEVICE; LUNG ARTERY PRESSURE; LUNG WEDGE PRESSURE; MALE; MEAN ARTERIAL PRESSURE; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; SURGICAL MORTALITY; SURGICAL RISK; SYSTOLIC BLOOD PRESSURE; TRANSLUMINAL VALVULOPLASTY;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; BALLOON VALVULOPLASTY; CHI-SQUARE DISTRIBUTION; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEASIBILITY STUDIES; FEMALE; HEART ARREST; HEART-ASSIST DEVICES; HEMODYNAMICS; HOSPITAL MORTALITY; HUMANS; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 84870955811     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24303     Document Type: Article

References (20)

1. Cribier A, Remadi F, Koning R, Rath P, Stix G, Letac B,. Emergency balloon valvuloplasty as initial treatment of patients with aortic stenosis and cardiogenic shock. N Engl J Med 1992; 326: 646.
2. McKay RG,. The mansfield scientific aortic valvuloplasty registry: Overview of acute hemodynamic results and procedural complications. J Am Coll Cardiol 1991; 17: 485-491.
3. Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI balloon valvuloplasty registry. Circulation 1991; 84: 2383-2397.
4. Hamid T, Eichhofer J, Clarke B, Mahadevan VS,. Aortic balloon valvuloplasty: Is there still a role in high-risk patients in the era of percutaneous aortic valve replacement? J Interv Cardiol 2010; 23: 358-361.
5. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607.
6. Godino C, Maisano F, Montorfano M, et al. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: The Milan experience. JACC Cardiovasc Interv 2010; 3: 1110-1121.
7. Lefevre T, Kappetein AP, Wolner E, et al. One year follow-up of the multicentre European PARTNER transcatheter heart valve study. Eur Heart J 2011; 32: 148-157.
8. Tanaka K, Rangarajan K, Azarbal B, Tobis JM,. Percutaneous ventricular assist during aortic valvuloplasty: Potential application to the deployment of aortic stent-valves. Tex Heart Inst J 2007; 34: 36-40.
9. Rajdev S, Irani A, Sharma S, Kini A,. Clinical utility of TandemHeart for high-risk tandem procedures: Percutaneous balloon aortic valvuloplasty followed by complex PCI. J Invasive Cardiol 2007; 19: E346-E349.
10. Gregoric ID, Loyalka P, Radovancevic R, Jovic Z, Frazier OH, Kar B,. TandemHeart as a rescue therapy for patients with critical aortic valve stenosis. Ann Thorac Surg 2009; 88: 1822-1826.
11. Jolly N,. Role of Impella 2.5 heart pump in stabilizing diastolic aortic pressure to avert acute hemodynamic collapse during coronary interventions. J Invasive Cardiol 2009; 21: E134-E136.
12. Dixon SR, Henriques JP, Mauri L, et al. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): Initial US experience. JACC Cardiovasc Interv 2009; 2: 91-96.
13. Sjauw KD, Konorza T, Erbel R, et al. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry. J Am Coll Cardiol 2009; 54: 2430-2434.
14. Ferreiro JL, Gomez-Hospital JA, Cequier AR, et al. Use of Impella Recover LP 2.5 in elective high risk percutaneous coronary intervention. Int J Cardiol 145: 235-237.
15. Harjai KJ, O'Neill WW,. Hemodynamic support using the Impella 2.5 catheter system during high-risk percutaneous coronary intervention in a patient with severe aortic stenosis. J Interv Cardiol 2010; 23: 66-69.
16. Londono JC, Martinez CA, Singh V, O'Neill WW,. Hemodynamic support with Impella 2.5 during balloon aortic valvuloplasty in a high-risk patient. J Interv Cardiol 2011; 24: 193-197.
17. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the society of cardiovascular anesthesiologists endorsed by the society for cardiovascular angiography and interventions and the society of thoracic surgeons. J Am Coll Cardiol 2006; 48: e1-e148.
18. Kapadia SR, Goel SS, Svensson L, et al. Characterization and outcome of patients with severe symptomatic aortic stenosis referred for percutaneous aortic valve replacement. J Thorac Cardiovasc Surg 2009; 137: 1430-1435.
19. Moreno PR, Jang IK, Newell JB, Block PC, Palacios IF,. The role of percutaneous aortic balloon valvuloplasty in patients with cardiogenic shock and critical aortic stenosis. J Am Coll Cardiol 1994; 23: 1071-1075.
20. Brinster DR, Byrne M, Rogers CD, et al. Effectiveness of same day percutaneous coronary intervention followed by minimally invasive aortic valve replacement for aortic stenosis and moderate coronary disease ("hybrid approach"). Am J Cardiol 2006; 98: 1501-1503.